key: cord-0957982-45jd9ffq authors: Stanly Paul, M. L.; Nadendla, Swathi; Sobhia, M Elizabeth title: Design and development of potent h-ACE2 derived peptide mimetics in SARS-CoV-2 Omicron variant therapeutics date: 2022-02-02 journal: bioRxiv DOI: 10.1101/2022.02.01.478632 sha: c716bc2ee4820317a5676186b008028ddfcb24bf doc_id: 957982 cord_uid: 45jd9ffq The pandemic of COVID-19 has become the global health challenge due to the emergence of new variants. The Receptor binding domain (RBD) of spike protein that makes direct interaction with ACE-2 has shown unique mutated residues in most of the variants of concern (VOC). Recently WHO declared the Omicron (B.1.1.529) as VOC considering it as a highly mutated variant which includes a total of 60 mutations out of which 15 mutations occurred in RBD region of SARS-CoV-2. Inhibition of Protein-protein (Omicron RBD-h-ACE2) interaction was already proved to inhibit the viral infection. In this study, by using molecular dynamic simulations efforts are made to explore the atomistic details of Omicron RBD-h-ACE2 interaction. Based on MD simulations, h-ACE2 motif is found to be interacting with omicron RBD domain. Interaction analysis had provided key residues interacting with Omicron-RBD that helped to extract h-ACE2 peptide. Here, rational design of the peptides that have resemblance with h-ACE2 is done and the peptide library is subjected for inhibition studies against Omicron-RBD. The current study helped to identify the significant peptides that can inhibit Omicron-RBD. Altogether the performed studies will provide an opportunity to develop potential therapeutic peptidomimetics effective against Omicron variant of SARS-CoV-2. Since its emergence of SARS-CoV-2 in Wuhan province in China (2019) the impacts created by SARS-CoV-2 and its variants are having impeccable effect on the society and health care system worldwide 1 3 . Omicron is considered as the most heavily mutated variant that has emerged so far with enhanced transmissibility and partial resistance to vaccine induced immunity 4, 5 . However, its closer sequence identity (99.63%) with alpha (B.1.1.7) variant suggests that omicron primary emergence in the population is way beyond its expectation even in vaccinated population. Genomic studies on the variant revealed that there are fifteen mutations in the omicron RBD region out of which five mutations are present at the core binding region. Three mutations S371L, S373P, S375F in the subdomain are clustered at a hairpin loop that has initiated a main conformational change compared to other mutated RBD structures in other variants. Studies revealed that the interacting residues are same when compared to wild type RBD indicating that the overall binding mode is conserved 6 . Spike protein is not only responsible for interaction with ACE-2 through RBD for entry into the host cell but is also a major inducer of neutralizing antibodies 7 . SARS Cov-2 is actively acquiring resistance since its emergence, hence cocktail of antibodies are required to produce desired clinical response whose production is comparatively expensive 8 . Inhibiting RBD-ACE-2 interactions by using peptides and peptidomimetics offers various advantages like high specificity and affinity and their ability to penetrate cell membranes 9 . Here, efforts are made for the design of peptide mimetic inhibitors of SARS-CoV-2 by mutation that are effective against the omicron variant 10 . For this study the, new SARS-CoV-2 variant genome sequence was taken from the GISAID Database (GISAID accession EPI_ISL_6752027) which was submitted on November 22, 2021 by a team of researchers from Botswana-Harvard HIV Reference laboratory using a Nanopore MinION device 11 . As a part of structure prediction of omicron RBD, the template selection was done by using BLAST-P search. Native crystal structure of RBD-ACE2 alpha variant complex in PDB (7NXA) 12 was taken as template among all others by considering the highest sequence identity of 93.30%. The multichain (omicron-RBD with ACE2) model structures generated through Modeller are further subjected to structure refinement. Electrostatic potential analysis provides guided parameters to design specific inhibitors against any biomolecules. But classical electrostatic potential analysis does not provide precise parameters due to non-consideration of solvent medium. Gaussian based smooth dielectric function considers the solvent medium that provides accurate computational calculations of electrostatic potentials. Here, Gaussian DelPhi program was used to analyze the electrostatic potential of both WT-RBD and omicron-RBD. Both WT-RBD and omicron-RBD along with hACE2 was subjected to 400ns of molecular dynamics simulation study to check folding and structural stability 13 . Desmond-maestro is used to prepare the complexes by adding TIP3P water, and neutralize the complexes by adding counter Na+ ions. Periodic boundary conditions (PBC) and OPLS3e forcefields were applied on the system before subjecting to the minimization process. Here we used Desmond standard NVT ensemble where constant pressure(1 bar) and brendsen thermostat with constant(300K) is maintained. Hydrogen bond restrains were considered by adding SHAKE algorithm whereas electro static forces by Particle Mesh Ewald (PME) algorithm in the MD run. Both WT and Omicron RBD-hACE2 systems were subjected to 400ns MD run. Most of the interactions between RBD-ACE2 are found to be from the α-1 helix of hACE2. So, mutating the residues of this helix may result in peptides that have higher binding affinity than ACE-2 becomes helpful in discovering of novel peptide inhibitors that prevent the RBD-ACE-2 interaction 10 . Here, the reference alpha helix peptide was taken from the ACE2-RBD homology model complex. The parent ACE2 alpha helix peptide in between Ile21 to Ser44 i.e. IEEQAKTFLDKFNHEAEDLFYQSS was found to interact with key binding residues of Omicron RBD. Based on the properties of amino acids on the apopeptide ( Figure 1 ) design of peptide mutant library (456 peptidomimetics) over omicron RBD is done by carefully considering the structural changes of the protein, for this process in-house script was used. The generated peptidomimetic library was systematically divided based on the properties shown on helix wheel ( Figure 1F ). Initially, a 453 membered peptide mimetic library was modelled by using inhouse scripts and subjected to molecular docking over Omicron RBD binding site. High ambiguity driven protein-protein docking (HADDOCK) is proved to be best docking server for protein-protein and protein-peptide docking. One feature that extricates it from other accessible software's is the usage of experimentally derived data from NMR, mutagenesis and the provided solution was found to be identical with experimentally derived structure. Both the interacting residues in peptide and protein are given as input along with the active site residues of receptor. By defining Ambiguous interacting residues (AIRS) the main advantage is that only the poses in which the ligand interacts with the active residues are sampled rather than selection based on conformational energies. A three step protocol is used for both the proteinprotein and protein-peptide docking where step-1 contains rigid docking process, step-2 contains semi flexible docking and step-3 includes refining structures in presence of water. Docking score is mainly dependent on the summation of reports got through these three steps (HADDOCK docking score = 1.0EvdW + 0.2Eelec + 1.0Edesol + 0.1EAIR) 10 . A detail docking cluster reports were generated by HADDOCK server. A default cut-off of RMSD (2Å) is set and acceptable structures are ranked among the clusters. Screening of peptide mimetics on Omicron RBD has provided key information on binding residues 10 . Out of the plethora of peptide library, fourteen peptides showed higher inhibition effect when compared with reference α-1 helix. Overall, the studies allowed to design novel peptide and peptidomimetic inhibitors that competitively bind to omicron RBD. The omicron RBD-ACE2 complex structure is modelled by using multichain script of Modeller. Initial protein interaction analysis provided binding residues with buried SASA(TYR489, TYR501, GLY502, SER496, PHE456, ARG498, ALA475, THR500, HID505, GLY476, ASN487, ARG493, TYR-453, SER494, TYR449) on RBD; Salt bridges ARG493-GLU35. P-P stacking(TYR501-TYR41) and vdW interactions were observed in between the following residues (PHE456-LYS31, THR500-TYR41, GLY476-GLN24, ARG493-HID43, SER494-HID34). Comparison of wildtype and omicron-RBD binding site revealed that omicrons mutated residues are noticeable longer side chains. This elucidates the significance of mutations in the tight binding process of omicron-RBD towards overall negatively charged h-ACE2. The modelled omicron-RBD in complex with ACE-2 is subjected to molecular dynamic simulations to get atomistic details of protein-protein interaction. Time dependent all atom molecular dynamics simulations is already proved to be an efficient tool to analyse the folding behaviour of the protein in biological conditions. During whole production run RMSD and RMSF is useful to investigate the structural changes and to assess the stability the protein complex. In our study, initially RMSD of C-alpha-backbone of Omicron-RBD-h-ACE2 complex is raised from 2.4 to 3.7Å, but in omicron-RBD RMSD raised from 2.7 to 3.3Å over the time period of 20ns whereas in h-ACE2 RMSD raised from 2.6 to 3.2Å over the time period of 70ns and remained stable over the period of 400ns. In the process of Omicron RBD stabilization, clear structural changes were observed stepwise over the time period of 400ns; step-1 is observed in between 20ns to 220ns at 2.7 to 3.3 Å and step-2 from 320 to 400ns 3.7 to 4.5 Å where the structure got stabilized (Figure 3 ). Secondary structure elements analysis showed that Omicron RBD consists of 8.95% helix 21.50% Strand with 30.45% total SSE. SSE components on the whole trajectory showed that alpha helices region in between SER-438S to SER-443 slowly disappeared during the evolution of protein complex ( Figure 4A ). provided major residues involved in omicron RBD and h-ACE2 binding interaction. Wild type RBD TYR489-TYR83, THR500-TYR41, TYR83-ASN87, GLY502-LYS353 are majorly occupying H-bonds. Unique H-bond interactions ASN-487-TYR83 , SER496-ASP38, TYR453-HIS34, GLN24-GLY476 were observed between omicron RBD-h ACE2. (Figure 5 ). All the peptides with respective mutated residues and reference peptide were docked with omicron-RBD considering the interacting residues of peptide and protein obtained as a part of protein interacting analysis as the active site residues that coincided with literature data. The fourteen peptides which scored more than the reference peptide (-109.1±6.3kcal/mol) ranging between (-114.0±8.8 to -127.8±2.1kcal/mol) has provided binding and affinity insights on the core binding site . Peptides with highest scores are subjected to further analysis and are tabulated below (Table: 1 ). Respective amino acids that scored highest are replaced at 13 positions resulting in mutated peptides (mutated residues are showed in red colour). -Comparatively the mutated peptides scored better than the reference from where clues are drawn for mutating the initial residues with high scored ones at respective positions resulting in peptides that scored thrice than reference. Host receptor recognition and attachment by virion is facilitated by interface of omicron RBD with h-ACE-2. Thus, design of peptides that have resemblance with h-ACE2 can inhibit the protein-protein interaction and be a potential therapeutic in order to combat the virus. The modelled complex is subjected to molecular dynamic simulation for insights into the atomistic details of protein-protein interactions. Ile21 to Ser44 residues of h-ACE-2 are considered as key residues that interact with omicron RBD domain and are mutated to generate a library of 453 novel peptides. Out of this, thirteen peptides exhibited stronger interaction with RBD than that of ACE-2 which are considered to be worthy for further investigation. Based on the interaction analysis of 14 bio mimetic peptides design of novel peptides is done that demonstrate higher binding affinity than wild type h-ACE2 derived peptide. The Emergence of SARS-CoV-2 Variant (s) and Its Impact on the Prevalence of COVID-19 Cases in the Nabatieh Region In-silico design of a potential inhibitor of SARS-CoV-2 S protein Omicron and Delta variant of SARS-CoV-2: a comparative computational study of spike protein Structural and computational insights into the SARS-CoV-2 Omicron RBD-ACE2 interaction Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV Human monoclonal antibodies for prophylaxis and therapy of viral infections Therapeutic peptides: technological advances driving peptides into development ACE-2-derived biomimetic peptides for the inhibition of spike protein of SARS-CoV Predictions of the SARS-CoV Omicron variant (B. 1.1. 529) spike protein receptor-binding domain structure and neutralizing antibody interactions Structural models of SARS-CoV-2 Omicron variant in complex with ACE2 receptor or antibodies suggest altered binding interfaces The effect of the multiple mutations in Omicron RBD on its binding to human ACE2 receptor and immune evasion: an investigation of molecular dynamics simulations. 2021. 14 SARS-CoV-2 B. 1.617 Indian variants: Are electrostatic potential changes responsible for a higher transmission rate? NIPER-Mohali computing facility is used for all computational studies. GNU plot is used to depict the statistical studies. Throughout the study process, Pymol is used to generate high quality images.